Paolo Rigotti
About
In The Last Decade
Paolo Rigotti
192 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 132
- Transplantation 2.5k
- Surgery 2.0k
- Public Health, Environmental and Occupational Health 1.1k
- Oncology 732
- Epidemiology 702
Countries citing papers authored by Paolo Rigotti
This map shows the geographic impact of Paolo Rigotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Rigotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Rigotti more than expected).
Fields of papers citing papers by Paolo Rigotti
This network shows the impact of papers produced by Paolo Rigotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Rigotti. The network helps show where Paolo Rigotti may publish in the future.
Co-authorship network of co-authors of Paolo Rigotti
This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Rigotti. A scholar is included among the top collaborators of Paolo Rigotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Rigotti. Paolo Rigotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | Kidney-paired-donation innescata con reni da donatore deceduto. Prima esperienza e sue implicazioni etiche | 1 |
| 5 | "Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy. | 19 |
| 6 | Eculizumab In Prevention Of Acute Antibody-Mediated Rejection In Sensitized Deceased-Donor Kidney Transplant Recipients : 1-Year Outcomes | 3 |
| 7 | 16 | |
| 8 | Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. | 3 |
| 9 | PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION | 1 |
| 10 | 3 | |
| 11 | 30 | |
| 12 | 30 | |
| 13 | 64 | |
| 14 | Carbon monoxide (CO) prevents apoptotic events related to ischemia/reperfusion (IR) injury in an hDAF pig-to-primate xenotransplantation model | 1 |
| 15 | 2 | |
| 16 | 40 | |
| 17 | 3 | |
| 18 | Is warm ischemia the main limiting factor in the use of non-heart-beating donors in renal transplantation? | 10 |
| 19 | Use of defibrotide in preventing vascular thrombosis in experimental pancreas transplantation | 2 |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.